Family Medicine Doctors in Burlington, VT Accepting Medicare

30 Family Medicine doctors found. Showing 21 - 30

Michael Ialeggio, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309

Alissa Warshaw, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 173 Saint Paul St, Burlington, VT 05401 Phone: 866-476-1321

Susan P. Shane, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 South Prospect Street, Fahc Family Medicine, Arnold 4, Burlington, VT 05401 Phone: 802-847-4237

Michelle Marie Paavola, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 425 Pearl St, Burlington, VT 05401 Phone: 802-656-3350

Cynthia Ames Haselton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 789 Pine St, Burlington, VT 05401 Phone: 802-864-0693    Fax: 802-860-6613

Diana Lynn Barnard, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care Smith 262, Burlington, VT 05401 Phone: 802-847-1023    Fax: 902-847-2929

Karla Martinez-dulmer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000

Deborah Richter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Pine Street, Burlington, VT 05401 Phone: 802-488-6300

Jillian Leigh Brennan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-264-8158    Fax: 802-860-4313

Dr. Vivian Esparza, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 789 Pine St, Burlington, VT 05401 Phone: 802-655-4422

News Archive

Logical Therapeutics to present its clinical study results on LT-NS001

Logical Therapeutics, Inc. (Logical), a biopharmaceutical company focused on developing products that treat medical conditions associated with inflammation, has been selected to present the results of its clinical study comparing the gastrointestinal (GI) safety of its lead product LT-NS001, vs. naproxen at the American College of Gastroenterology's (ACG) Annual Scientific Meeting on October 27, 2009.

Pittsburgh researchers combine Viscotek GPC and Zetasizer Nano in work on novel polymers for drug delivery

Molecular weight and molecular weight distribution measurements are a basic necessity in studying the synthesis of the novel polymers being carried out by researchers at the Department of Bioengineering at the University of Pittsburgh. For the Pittsburgh team, the applications and technical expertise provided by Malvern Panalytical is a significant factor in their use of the company's Viscotek gel permeation chromatography (GPC) system to characterize polymer molecular weight, prior to applying the Zetasizer Nano for zeta potential measurements to study inter-molecular interactions.

Study highlights significant concerns about a growing issue of sex-selective abortion in Nepal

Detailed, new analysis published this week in the British Medical Journal (BMJ) Open highlights significant concerns about a growing issue of sex selective abortion of girls in Nepal.

FDA seeks expert advice on risks and benefits of MoM hip systems

The U.S. Food and Drug Administration today announced that it is seeking expert scientific and clinical advice on the risks and benefits of metal-on-metal (MoM) hip systems as well as potential patient and practitioner recommendations on the use of MoM hip systems and the management of patients implanted with such devices. FDA will discuss these issues at a two-day expert advisory panel meeting on June 27-28, 2012.

Caltech biologists offer new insight into causes of IBD and colon cancer

We are not alone-even in our own bodies. The human gut is home to 100 trillion bacteria, which, for millions of years, have co-evolved along with our digestive and immune systems. Most people view bacteria as harmful pathogens that cause infections and disease. Other, more agreeable, microbes (known as symbionts) have taken a different evolutionary path, and have established beneficial relationships with their hosts.

Read more Medical News

› Verified 8 days ago

• 1
• 2(current)